| Therapeutic cell engineering with surface-conjugated synthetic nanoparticles MT Stephan, JJ Moon, SH Um, A Bershteyn, DJ Irvine Nature medicine 16 (9), 1035-1041, 2010 | 785 | 2010 |
| Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses JJ Moon, H Suh, A Bershteyn, MT Stephan, H Liu, B Huang, M Sohail, ... Nature materials 10 (3), 243-251, 2011 | 637 | 2011 |
| HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ... PLoS medicine 9 (7), e1001245, 2012 | 461 | 2012 |
| Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models BL Jewell, E Mudimu, J Stover, D Ten Brink, AN Phillips, JA Smith, ... The lancet HIV 7 (9), e629-e640, 2020 | 445 | 2020 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 251 | 2014 |
| Bioactive hydrogels with an ordered cellular structure combine interconnected macroporosity and robust mechanical properties AN Stachowiak, A Bershteyn, E Tzatzalos, DJ Irvine Advanced Materials 17 (4), 399-403, 2005 | 192 | 2005 |
| Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 175 | 2015 |
| Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy AR Kirtane, O Abouzid, D Minahan, T Bensel, AL Hill, C Selinger, ... Nature communications 9 (1), 1-12, 2018 | 165 | 2018 |
| Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial RV Barnabas, AA Szpiro, H van Rooyen, S Asiimwe, D Pillay, NC Ware, ... The lancet Global health 8 (10), e1305-e1315, 2020 | 129 | 2020 |
| Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, ... Annals of internal medicine 174 (3), 344-352, 2021 | 127 | 2021 |
| Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine A Bershteyn, MC Hanson, MP Crespo, JJ Moon, AV Li, H Suh, DJ Irvine Journal of controlled release 157 (3), 354-365, 2012 | 126 | 2012 |
| Polymer-supported lipid shells, onions, and flowers A Bershteyn, J Chaparro, R Yau, M Kim, E Reinherz, L Ferreira-Moita, ... Soft matter 4 (9), 1787-1791, 2008 | 125 | 2008 |
| Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response PK Drain, J Dorward, A Bender, L Lillis, F Marinucci, J Sacks, A Bershteyn, ... Clinical microbiology reviews 32 (3), 10.1128/cmr. 00097-18, 2019 | 122 | 2019 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 113 | 2022 |
| HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making HIV Modelling Consortium Treatment as Prevention Editorial Writing Group PLoS Medicine 9 (7), e1001259, 2012 | 101 | 2012 |
| Implementation and applications of EMOD, an individual-based multi-disease modeling platform A Bershteyn, J Gerardin, D Bridenbecker, CW Lorton, J Bloedow, ... Pathogens and disease 76 (5), fty059, 2018 | 88 | 2018 |
| Sexual partnership age pairings and risk of HIV acquisition in rural South Africa A Akullian, A Bershteyn, D Klein, A Vandormael, T Bärnighausen, ... Aids 31 (12), 1755-1764, 2017 | 81 | 2017 |
| Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: a randomized clinical trial C Johnston, ER Brown, J Stewart, HCS Karita, PJ Kissinger, J Dwyer, ... EClinicalMedicine 33, 2021 | 78 | 2021 |
| Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells K Tai, G Pelled, D Sheyn, A Bershteyn, L Han, I Kallai, Y Zilberman, ... Tissue Engineering Part A 14 (10), 1709-1720, 2008 | 75 | 2008 |
| Trajectory of viral RNA load among persons with incident SARS-CoV-2 G614 infection (Wuhan strain) in association with COVID-19 symptom onset and severity HCS Karita, TQ Dong, C Johnston, KM Neuzil, MK Paasche-Orlow, ... JAMA Network Open 5 (1), e2142796-e2142796, 2022 | 73 | 2022 |
